| UCH CCRs attended | Number of Residents | Percentage Meeting Tier |
| 0 | 118 | 10.9% |
| 1 | 139 | 12.9% |
| 2 | 114 | 10.6% |
| 3+ | 707 | 65.6% |
| Module Completions (by 10/1 Deadline) | Number of Eligible Residents | Completion Percentage |
| 853 | 1078 | 79.1% |
| DH CCRs attended | Number of Residents | Percentage Meeting Tier |
| 0 | 281 | 29.1% |
| 1 | 90 | 9.3% |
| 2+ | 595 | 61.6% |

| CHCO CCRs attended | Number of Residents/Fellows | Percentage Meeting Tier |
| 0 | 25 | 14.4% |
| 1 | 15 | 8.6% |
| 2+ | 134 | 77.0% |
| CHCO Target Zero sessions attended | Number of Residents/Fellows | Percentage Meeting Tier |
| 0 | 21 | 12.1% |
| 1 | 10 | 5.7% |
| 2+ | 143 | 82.2% |
| Program | Tier 1 - Completion of A3 ($400) | Tier 2 -ORRQIRP Submission/Approval ($400) | Tier 3 - Baseline Data or Results ($200) |
| Child and Adolescent Psychiatry | Complete | Complete | Complete |
| Child Neurology | Complete | Complete | Complete |
| Medical Biochemical Genetics | Complete | Complete | Complete |
| Neonatal-Perinatal Medicine | Complete | Complete | Complete |
| Pediatric Anesthesiology | Complete | Complete | Complete |
| Pediatric Cardiology | Complete | Complete | Complete |
| Pediatric Critical Care Medicine | Complete | Complete | Complete |
| Pediatric Epilepsy | Complete | Complete | Complete |
| Pediatric Gastroenterology | Complete | Complete | Complete |
| Pediatric Genetic Precision Medicine Fellowship | No Project Submitted | No Project Submitted | No Project Submitted |
| Pediatric Hematology/Oncology | Complete | Complete | Complete |
| Pediatric Interventional and Congenital Cardiology | Complete | Complete | Complete |
| Pediatric Nephrology | Complete | Complete | Complete |
| Pediatric Neuro-Oncology | Complete | Complete | Complete |
| Pediatric Orthopedic Surgery | No Project Submitted | No Project Submitted | No Project Submitted |
| Pediatric Otolaryngology | Complete | Complete | Complete |
| Pediatric Rehabilitation | Complete | Complete | Complete |
| Pediatric Urology | Complete | Complete | Pending |
Please contact [email protected] to address any discrepancies.